FDA Inspection 1295032 — Changzhou Qianhong Biopharma Co., Ltd.
The FDA completed an inspection of Changzhou Qianhong Biopharma Co., Ltd. on Oct 31, 2025 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 31, 2025
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Changzhou (China)